*AccuQuik™ COVID-19 Ag Test Kit is CE, ISO, USFDA Listed certified.
*AccuQuik™ COVID-19 Ag Test Kit is manufactured in our facilities located in China/India/USA.
COVID-19 Antigen Rapid Test (Swab)
Nasopharyngeal (Swab);Oropharyngeal (Swab)
Cassette
20 cassettes, 20 nasopharyngeal swabs, 20 extraction buffers (w/ dropper cap), 1 positive control swab/kit;25 cassettes, 25 nasopharyngeal test, 25 buffer bottles/kit;25 cassettes, 25 oropharyngeal test, 25 buffer bottles/kit
Product Information
AdvaCare is a CE, ISO and USFDA Listed manufacturer of COVID-19 (Coronavirus) Antigen Rapid Test Device.
AccuQuik COVID-19 Antigen Rapid Test Device kit is a lateral flow immunoassay intended for qualitative detection of nucleocapsid protein antigen in direct nasal swabs or nasopharyngeal swab specimens from individuals suspected of COVID-19 (SARS-CoV-2). It is intended to be used by healthcare professionals as an aid in the detection of COVID-19 (SARS-CoV2) Antigen, within the first seven days of symptom onset.
AccuQuik COVID-19 Antigen Rapid Test Kit detects COVID-19 SARS-CoV-2 Antigen in one test within 10-15 minutes. The test is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests.
The COVID-19 Antigen Rapid Test does not differentiate between SARS-CoV and SARS-CoV- 2. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen.
Each product box kit includes 25 cassette, 25 nasopharyngeal or oropharyngeal specimen collection swabs, 25 extraction tubes (w/ dropper cap), 3 buffer bottles, 1 plastic tube workstation/kit.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results from patients with symptom onset beyond seven days, should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19.
Our COVID-19 Antigen Rapid Test kit has 94.6% Clinical Sensitivity and 98.5% Clinical Specificity and it is used to quickly determine who has an active infection among suspected patients.
-
For more information about our COVID-19 (Coronavirus) Antigen Rapid Test
email us at: info@advacarepharma.com
Related Products
Additional Information
Important Notice for Distributors
We, at AdvaCare, have been working around the clock to address this global pandemic, with a special focus on the early detection of COVID-19, to expedite development of our revolutionary testing solution. We stand on the front lines in the fight against novel coronavirus (COVID-19)!
As AdvaCare production lines are running at full capacity to meet demand, delivery times are according to when orders are placed.
Contact us today to Receive Prices, Specifications and Shipment Schedule.
INTERESTED IN MORE PRODUCTS?
Discover more products we already distribute in more than 65 countries worldwide you can consider to distribute to contain COVID-19 outbreak:
Precautions
- Do not use after expiration date. Do not use if pouch is damaged or open. Do not reuse the tests;
- Do not mix components from different kit lots. Avoid cross-contamination of specimens by using a new specimens collection container for each specimen obtained;
- Do not eat, drink or smoke in the area where the specimens or kits are handled;
- Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout testing and follow the standard procedures for proper disposal of specimens;
- Wear protective clothing such as laboratory coats, disposable gloves and eye protection when specimens are being tested;
- Humidity and temperature can adversely affect results;
- The extraction buffer contains a salt solution if the solution contacts the skin or eyes, flush with copious amounts of water;
- Discard the using testing materials in accordance with local regulations.